EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PVT1‐104aa derived from the 8q24 gene desert promotes colorectal cancer tumorigenesis

Maoguang Ma, Mingdian Wang, Yufei Yang, Dakui Luo, Weixing Dai iD, Yiwei Li, Sanjun Cai, Shaobo Mo iD, Qingguo Li iD, Xinxiang Li iD

Clinical and Translational Medicine · 2026

DOI: 10.1002/ctm2.70654 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Medicine, 2026. Verfasst von Maoguang Ma und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, RNA, Long Noncoding, Carcinogenesis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Youth Science Foundation of Zhongshan Hospital, Fudan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Current therapeutic outcomes for advanced colorectal cancer (CRC) remain suboptimal, and chemotherapy‐based regimens continue to be the mainstay of treatment. Circular RNAs (circRNAs) can serve as templates for translating short peptides or proteins, and the resulting products actively regulate malignant tumour progression, making them attractive therapeutic targets.

Methods

We identified the novel protein PVT1‐104aa translated from circPVT1, which is generated by back‐splicing of the non‐coding PVT 1 gene. Its expression and clinical significance were examined in CRC clinical specimens and cell lines. Proliferation, metastasis, and tumour growth were assessed by CCK‐8, colony formation, transwell, wound healing, and xenograft syngeneic tumour models. Mechanistic studies were performed by immunoprecipitation, ubiquitination assays, and protein half‐life analysis. The relationship between PVT1‐104aa, c‐Myc, and PD‐L1 was evaluated by promoter reporter assays, ChIP‐qPCR, and immunohistochemistry. The therapeutic efficacy of combining PVT1‐104aa inhibition with anti‐PD‐L1 therapy was tested in vivo.

Results

PVT1‐104aa was significantly overexpressed in CRC and correlated with poor patient prognosis. Functionally, it drove tumour progression by promoting proliferation and metastasis. Mechanistically, PVT1‐104aa enhanced c‐Myc phosphorylation at Ser62, disrupted the c‐Myc‐FBW7 interaction, and thereby inhibited ubiquitin‐mediated degradation of c‐Myc, as shown by accelerated c‐Myc turnover upon PVT1‐104aa knockdown. In addition, PVT1‐104aa regulated PD‐L1 expression through c‐Myc. Combining anti‐PVT1‐104aa with anti‐PD‐L1 therapy suppressed CRC growth and increased CD4 + and CD8 + T cell infiltration in xenograft syngeneic tumour models and CRC tissues.

Conclusions

Our results uncover a pathogenic role of the PVT1‐originated molecular species PVT1‐104aa and suggest that targeting this pathway represents a promising therapeutic strategy for CRC treatment. Key points Circ‐PVT1 is upregulated in CRC patients and encoded a novel protein: PVT1‐104aa. PVT1‐104aa promotes CRC progression and predicts worse prognosis. PVT1‐104aa enhance Myc expression through inhibition of Myc ubiquitination. PVT1‐104aa regulate PD‐L1 expression of CRC cells and modulate T cells infiltration in vivo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsRNA, Long NoncodingCarcinogenesisHumansAnimalsMiceFemaleCell Line, TumorMaleCell Proliferation

Stichwörter der Autor:innen

PVT1‐104aa oncopeptidecircRNAcolorectal cancercombination immunotherapyc‐Myc ubiquitination

Substanzen

PVT1 long-non-coding RNA, humanRNA, Long Noncoding

Autor:innen und Institutionen

  • Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.

ORCID-Profile: Weixing Dai, Shaobo Mo, Qingguo Li, Xinxiang Li

Förderung

  • National Natural Science Foundation of China
  • Youth Science Foundation of Zhongshan Hospital, Fudan University

Zitieren

APA

Ma, M., Wang, M., Yang, Y., Luo, D., Dai, W., Li, Y., Cai, S., Mo, S., Li, Q., & Li, X. (2026). PVT1‐104aa derived from the 8q24 gene desert promotes colorectal cancer tumorigenesis. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.70654

Vancouver

Ma M, Wang M, Yang Y, Luo D, Dai W, Li Y, et al. PVT1‐104aa derived from the 8q24 gene desert promotes colorectal cancer tumorigenesis. Clinical and Translational Medicine. 2026. doi:10.1002/ctm2.70654

BibTeX
@article{Ma2026,
  author = {Ma, Maoguang and Wang, Mingdian and Yang, Yufei and Luo, Dakui and Dai, Weixing and Li, Yiwei and Cai, Sanjun and Mo, Shaobo and Li, Qingguo and Li, Xinxiang},
  title = {PVT1‐104aa derived from the 8q24 gene desert promotes colorectal cancer tumorigenesis},
  journal = {Clinical and Translational Medicine},
  year = {2026},
  doi = {10.1002/ctm2.70654}
}
Kostenlos starten →